Heavy menstrual bleeding diagnosis and medical management

被引:38
作者
Intira Sriprasert
Tarita Pakrashi
Thomas Kimble
David F. Archer
机构
[1] Chiang Mai University,Department of Obstetrics and Gynecology, Faculty of Medicine
[2] Jones Institute for Reproductive Medicine/Eastern Virginia Medical School,Department of Obstetrics and Gynecology
[3] Eastern Virginia Medical School,CONRAD Clinical Research Center, Department of Obstetrics and Gynecology
关键词
Heavy menstrual bleeding; Abnormal uterine bleeding; Tranexamic acid; Combination hormonal contraceptives; Non-steroidal anti-inflammatory drugs; Danazol;
D O I
10.1186/s40834-017-0047-4
中图分类号
学科分类号
摘要
Heavy menstrual bleeding (HMB) is a common gynecological problem that has a significant impact on a woman’s quality of life and the activities of daily living. Due to the difficulty in accurately describing menstrual bleeding abnormalities using older terminology, the PALM-COEIN classification system of the Federation Internationale de Gynecologie et d’Obstetrique was proposed to describe and identify the etiology of abnormal endometrial bleeding. As there is no single pathway that is associated with HMB, there are several therapeutic interventions involving different molecular pathways to reduce HMB. This article will highlight the current evidence as it relates to the etiology of HMB as well as medical modalities of treatment.
引用
收藏
相关论文
共 280 条
[41]  
Blumenthal P(2000)Endometrial leukocytes and menstruation Hum Reprod Update 6 16-103
[42]  
Dubois RW(2002)Leukocyte networks and human endometrial remodelling J Reprod Immunol 57 95-610
[43]  
Jensen JT(2003)The efficacy of non-contraceptive uses for hormonal contraceptives Med J Aust 178 621-267
[44]  
Lefebvre P(2015)Medical Management of Heavy Menstrual Bleeding: a comprehensive review of the literature Obstet Gynecol Surv. 70 115-44
[45]  
Laliberte F(1977)Acceptability of an oral-contraceptive that reduces frequency of menstruation - tri-cycle pill regimen Br Med J 2 487-331
[46]  
Sarda SP(2006)Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives Contraception 74 359-219
[47]  
Law A(2011)Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest Eur J Contracept Reprod Health Care 16 258-725
[48]  
Pocoski J(2016)U.S. medical eligibility criteria for contraceptive use, 2016 MMWR Recomm Rep 65 1-239
[49]  
Overton C(1987)A multicentered phase iii comparative clinical trial of depot-Medroxyprogesterone acetate given every three months at doses of 100mg or 150mg ii The Comparison of Bleeding Patterns Contraception 35 591-277
[50]  
Hargreaves J(2011)Gonadotropin releasing hormone agonists: expanding vistas Indian J Endocrinol Metab 15 261-715